Funder Introduction:
Anticancer Fund is a non-profit organization dedicated to funding clinical research in oncology, particularly focusing on clinical trials that have direct benefits for cancer patients. They aim to fund trials that can provide a significant impact on the survival and quality of life of cancer patients.

Call Overview:
The Anticancer Fund invites applications for funding clinical research projects, including trials that test innovative therapies for cancer patients. The organization prioritizes research that offers patient benefit, scientific quality, and is not commercially driven. They are particularly interested in trials focused on orphan diseases or areas underrepresented by the pharmaceutical industry.

Objectives:
The objective of this funding opportunity is to support clinical trials that focus on increasing cancer patient survival rates or improving the cure rate, especially for cancers where there are limited or no effective treatments.

Next Submission Deadline: Applications are accepted on a rolling basis.

• Applicant Profile: Open to academic researchers, research institutions, or hospitals conducting clinical trials in oncology.

• Research Focus: The trial must be centered on oncology and aim to benefit cancer patients.

• Research Phases: Anticancer Fund supports trials at any stage, including Phase I, II, or III.

• Funding Requirements: The project must be scientifically sound and demonstrate clear patient benefit, with minimal commercial interests involved.

• Exclusion Criteria: Applications from pharmaceutical companies, biotech companies, or startups are not eligible.

In case of interest, please click on "m'interessa" and we will contact you.